Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.25 | N/A |
| PEG Ratio (TTM) | 0.68 | N/A |
| P/S Ratio (TTM) | 1.34 | N/A |
| P/B Ratio (TTM) | 1.63 | N/A |
| P/FCF Ratio (TTM) | 8.58 | N/A |
| Price to 5YR AVG Earnings Ratio | -20.86 | N/A |
| Price to 5YR AVG FCF Ratio | 72.25 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.38% | N/A |
| ROE (TTM) | 6.17% | N/A |
| Net Profit Margin (TTM) | 5.29% | N/A |
| ROIC 5YR AVG | -6.53% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1,040.10% | 21.91% | 52.33% |
| Revenue | 4.06% | 198.03% | 119.23% |
| Net Income | 1,071.17% | -51.16% | 8.34% |
| Cash Flow | 41.01% | 141.21% | 113.77% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.24 | N/A |
| Quick Ratio (TTM) | 1.22 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 33.03 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.94 | N/A |
| LTL to 5YR AVG FCF | 5.64 | N/A |
| Shares Outstanding Growth 5YR AVG | 247.00% | N/A |